Lake Villa, IL, United States of America

Michelle Chalmers


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1998-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michelle Chalmers: Innovator in Viral Detection Technologies

Introduction

Michelle Chalmers is a prominent inventor based in Lake Villa, IL (US). She has made significant contributions to the field of viral detection, holding 2 patents that showcase her innovative approach to medical technology. Her work focuses on the detection and analysis of viruses, which is crucial for advancing healthcare solutions.

Latest Patents

Chalmers' latest patents include groundbreaking methods for utilizing the TT virus. The first patent relates to nucleic oligomer primers or probes that are useful for the detection of TTV in test samples. This invention also provides assays that utilize these primers and probes, along with test kits containing them. Furthermore, her invention encompasses the use of TTV nucleotide sequences as nucleic acid vectors and as markers for determining transmission between individuals, as well as the route of transmission. Additionally, she has developed a method for detecting TTV infection prior to xenotransplantation of a tissue or organ. Another significant patent focuses on the detection of hepatitis GB virus genotypes, specifically HGBV-C oligonucleotides from the 5' end of HGBV-C, which are useful for the detection and genotyping of HGBV-C isolates.

Career Highlights

Michelle Chalmers is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to apply her innovative ideas in a practical setting, contributing to advancements in viral detection technologies.

Collaborations

Throughout her career, Chalmers has collaborated with notable colleagues, including Thomas P. Leary and James Carl Erker. These collaborations have further enriched her research and development efforts in the field.

Conclusion

Michelle Chalmers is a remarkable inventor whose work in viral detection technologies has the potential to significantly impact healthcare. Her innovative patents and contributions to Abbott Laboratories Corporation highlight her dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…